In a year marked by macroeconomic uncertainty and renewed trade tensions that have shaken the equity market, CVS Health CVS has emerged as an unexpected outperformer. After a rough 2024, marked by ...

The healthcare sector, as measured by Health Care Select Sector SPDR Fund (NYSEARCA:XLV), with 12.12% weightage on the S&P ...

CVS Health surged 10% intraday and ended yesterday 6% higher. Check out why I think that CVS stock offers a significant ...

We’re nearing the end of the calendar-year Q1, with many S&P 500 stocks delivering strong performances year-to-date despite ...

Year to date, the S&P 500 is now down nearly 4.5%, and many investors are worried that there could be further declines coming. The best-performing stock on this list is CVS Health, which has risen ...

CVS Health (CVS) closed at $68.07, indicating a +0.13% shift from the previous trading day. While many stocks in the S&P 500 ETF posted dismal performance in the just-concluded quarter ...

Q1’s top S&P 500 performers held strong despite tariffs ... Analyst consensus shows only Newmont and CVS have potential upside of 25.8% and 13.2%, respectively, based on median price targets.

In November 2024, CVS Health appointed Prem Shah as the Group President, responsible for the operational performance across CVS Caremark, CVS Pharmacy, and the company's Healthcare Delivery ...

The healthcare sector, as measured by Health Care Select Sector SPDR Fund (NYSEARCA:XLV), with 12.12% weightage on the S&P 500, bagged a ... look at the sector’s performance and where its ...

The best-performing S&P 500 stocks of Q1 2025 include CVS Health, Philip Morris, Newmont, and AT&T, all outperforming amid ...